Sarah Cannon Transplant & Cellular Therapy Program at Research Medical Center
The Sarah Cannon Transplant & Cellular Therapy Program at Research Medical Center provides specialized care for acute leukemia and complex blood cancer patients. The program began adult autologous blood and marrow transplant services in 2019 and is FACT accredited. Comprehensive blood cancer and transplant services are provided in our dedicated outpatient blood cancer center and our dedicated inpatient oncology unit, supported by a multidisciplinary team of specialists and staffed by oncology-certified nurses.
Sarah Cannon HCA Midwest Health offers an Oncology Alert Patient Care Program, the only program in the region that focuses on promptly identifying and treating immunocompromised oncology patients arriving through the cancer clinic or the Emergency Room. The program provides special training to ER and clinic staff to identify and address the unique needs of chemotherapy patients.
Sarah Cannon Transplant & Cellular Therapy Program at Research Medical Center provides a clinical research program to support overall patient care. We offer additional therapeutic options through clinical trials, bringing innovative care options and immunotherapies to patients close to home. These blood cancer clinical trials are available through Sarah Cannon Research Institute.
Click here to learn more about blood cancer care at HCA Midwest Health.